Why TG Therapeutics Stock Is Crushing It Today
The biopharmaceutical company's Q3 update was music to investors' ears.
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of TG Therapeutics, Inc. - TGTX
/PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of TG Therapeutics, Inc. ("TG Therapeutics" or the "Company") (NASDAQ: TGTX). Such...
Why TG Therapeutics Stock Is Crashing Today
The drugmaker delivered a couple of surprises in Q2.
Why Apellis Pharmaceuticals, TG Therapeutics, and Viking Therapeutics Were on the Move Today
These three biotech stocks were on the volatile side today.
TG Therapeutics (TGTX) Reports Q1 Loss, Tops Revenue Estimates
TG Therapeutics (TGTX) delivered earnings and revenue surprises of 22.22% and 105.94%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?
3 Top Biotech Stocks Defying the Bear Market
All three companies have therapies with strong sales potential.
Why Shares of TG Therapeutics Soared on Tuesday
Early reports of strong sales for its recently approved multiple sclerosis drug gave the stock a jolt.